AMYL THERAPEUTICS
Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β (Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
AMYL THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2020-11-01
Address:
Liège, Liege, Belgium
Country:
Belgium
Website Url:
http://www.amyltx.com
Total Employee:
1+
Status:
Active
Total Funding:
29.7 M EUR
Technology used in webpage:
Euro CrUX Top 50m CrUX Dataset MediaElement.js
Similar Organizations
Cloudbreak Therapeutics
Cloudbreak Therapeutics is a clinical stage biotechnology company
Complement Therapeutics
Complement Therapeutics operates as a preclinical stage company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Freeline
Freeline Therapeutics is a biotechnology company focused on developing liver directed gene therapies for a range of diseases.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Relief Therapeutics
Relief Therapeutics is a clinical stage biotechnology company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Meusinvest (Noshaq)
Meusinvest (Noshaq) investment in Series A - Amyl Therapeutics
Evren Ucok
Evren Ucok investment in Series A - Amyl Therapeutics
Mérieux Equity Partners
Mérieux Equity Partners investment in Series A - Amyl Therapeutics
Kenneth Buckfire
Kenneth Buckfire investment in Series A - Amyl Therapeutics
6K Venture Capital
6K Venture Capital investment in Series A - Amyl Therapeutics
Ifoghas Investments
Ifoghas Investments investment in Series A - Amyl Therapeutics
Meusinvest (Noshaq)
Meusinvest (Noshaq) investment in Series A - Amyl Therapeutics
Smedvig
Smedvig investment in Series A - Amyl Therapeutics
Mérieux Equity Partners
Mérieux Equity Partners investment in Series A - Amyl Therapeutics
Sambrinvest
Sambrinvest investment in Series A - Amyl Therapeutics
Official Site Inspections
http://www.amyltx.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108